CHD

Tinley Park, Illinois, August 19, 2026 Hematogenix has announced that its proprietary Multiple Myeloma Minimal Residual Disease (MM MRD)...

Newport Beach, California, August 19, 2026 Renata Medical, a medical technology company focused on pediatric congenital heart disease (CHD),...